Romero Matthew, Keyel Michelle, Shi Guilan, Bhattacharjee Pushpak, Roth Robyn, Heuser John E, Keyel Peter A
Department of Biological Sciences, Texas Tech University, Lubbock, TX, USA.
Department of Cell Biology and Physiology, Washington University of Saint Louis, St. Louis, MO, USA.
Cell Death Differ. 2017 May;24(5):798-808. doi: 10.1038/cdd.2017.11. Epub 2017 Feb 10.
Pore-forming toxins (PFTs) are used by both the immune system and by pathogens to disrupt cell membranes. Cells attempt to repair this disruption in various ways, but the exact mechanism(s) that cells use are not fully understood, nor agreed upon. Current models for membrane repair include (1) patch formation (e.g., fusion of internal vesicles with plasma membrane defects), (2) endocytosis of the pores, and (3) shedding of the pores by blebbing from the cell membrane. In this study, we sought to determine the specific mechanism(s) that cells use to resist three different cholesterol-dependent PFTs: Streptolysin O, Perfringolysin O, and Intermedilysin. We found that all three toxins were shed from cells by blebbing from the cell membrane on extracellular microvesicles (MVs). Unique among the cells studied, we found that macrophages were 10 times more resistant to the toxins, yet they shed significantly smaller vesicles than the other cells. To examine the mechanism of shedding, we tested whether toxins with engineered defects in pore formation or oligomerization were shed. We found that oligomerization was necessary and sufficient for membrane shedding, suggesting that calcium influx and patch formation were not required for shedding. However, pore formation enhanced shedding, suggesting that calcium influx and patch formation enhance repair. In contrast, monomeric toxins were endocytosed. These data indicate that cells use two interrelated mechanisms of membrane repair: lipid-dependent MV shedding, which we term 'intrinsic repair', and patch formation by intracellular organelles. Endocytosis may act after membrane repair is complete by removing inactivated and monomeric toxins from the cell surface.
成孔毒素(PFTs)被免疫系统和病原体用来破坏细胞膜。细胞试图通过各种方式修复这种破坏,但细胞所使用的确切机制尚未完全了解,也未达成共识。目前的膜修复模型包括:(1)斑块形成(例如,内部囊泡与质膜缺陷融合),(2)孔的内吞作用,以及(3)通过细胞膜起泡使孔脱落。在本研究中,我们试图确定细胞用于抵抗三种不同胆固醇依赖性PFTs的具体机制:链球菌溶血素O、产气荚膜梭菌溶血素O和中间溶血素。我们发现,所有这三种毒素都通过细胞膜在细胞外微泡(MVs)上起泡而从细胞中脱落。在研究的细胞中独一无二的是,我们发现巨噬细胞对这些毒素的抵抗力要强10倍,但它们脱落的囊泡比其他细胞明显要小。为了研究脱落机制,我们测试了在孔形成或寡聚化方面存在工程缺陷的毒素是否会脱落。我们发现寡聚化对于膜脱落是必要且充分的,这表明钙内流和斑块形成对于脱落不是必需的。然而,孔形成会增强脱落,这表明钙内流和斑块形成会增强修复。相比之下,单体毒素会被内吞。这些数据表明,细胞使用两种相互关联的膜修复机制:脂质依赖性的MV脱落,我们称之为“内在修复”,以及细胞内细胞器形成斑块。内吞作用可能在膜修复完成后通过从细胞表面去除失活的单体毒素而起作用。